Relaro Medical Trials

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Depression5 trials
• Insomnia2 trials
• Autism1 trial

Phase

• Phase 34 trials
• Phase 21 trial
• Phase 41 trial

Status

• Completed5 trials
• Active, not recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC4 trials
• COMPASS Pathways1 trial
• Vertero Therapeutics1 trial

Running trials

• Active, not recruiting

  Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

  NCT05711940· Phase 3· COMPASS Pathways· Source

Closed trials

• Recruiting

  Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  NCT06559306· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

  NCT04895215· Phase 2· Vertero Therapeutics· Source

• Completed

  A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

  NCT04599855· Phase 4· Janssen Research & Development, LLC· Source

• Completed

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

  NCT04533529· Phase 3· Janssen Research & Development, LLC· Source